AI-Enabled Microfluidics for Respiratory Pathogen Detection
Sensors · 17.09.2025 · 25 (18) · 5791
DOI: 10.3390/s25185791 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Sensors, online erschienen am 17.09.2025. Verfasst von Daoguangyao Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technology, Beijing Institute of Technology, Beijing 100081, China. Hauptthemen laut MEDLINE: Artificial Intelligence, Microfluidics, Microfluidic Analytical Techniques, Respiratory Tract Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Respiratory infectious diseases, such as COVID-19, influenza, and tuberculosis, continue to impose a significant global health burden, underscoring the urgent demand for rapid, sensitive, and cost-effective diagnostic technologies. Integrated microfluidic platforms offer compelling advantages through miniaturization, automation, and high-throughput processing, enabling “sample-in, answer-out” workflows suitable for point-of-care applications. However, their clinical deployment faces challenges, including the complexity of sample matrices, low-abundance target detection, and the need for reliable multiplexing. The convergence of artificial intelligence (AI) with microfluidic systems has emerged as a transformative paradigm, addressing these limitations by optimizing chip design, automating sample pre-processing, enhancing signal interpretation, and enabling real-time feedback control. This critical review surveys AI-enabled strategies across each functional layer of respiratory pathogen diagnostics: from chip architecture and fluidic control to amplification analysis, signal prediction, and smartphone/IoT-linked decision support. We highlight key areas where AI offers measurable benefits over conventional methods. To transition from research prototypes to clinical tools, future systems must become more adaptive, data-efficient, and clinically insightful. Advances such as sensor-integrated chips, privacy-preserving machine learning, and multimodal data fusion will be essential to ensure robust performance and meaningful outputs across diverse scenarios. This review outlines recent progress, current limitations, and future directions. The rapid development of AI and microfluidics presents exciting opportunities for next-generation pathogen diagnostics, and we hope this work contributes to the advancement of intelligent, point-of-care testing (POCT) solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medical Technology, Beijing Institute of Technology, Beijing 100081, China.
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
- MicroTech Medical (Hangzhou) Co., Ltd., Hangzhou 311100, China.
ORCID-Profile: Yulin Deng
Zitieren
APA
Zhang, D., Lv, X., Jiang, H., Fan, Y., Liu, K., Wang, H., & Deng, Y. (2025). AI-Enabled Microfluidics for Respiratory Pathogen Detection. Sensors, 25(18), 5791. https://doi.org/10.3390/s25185791
Vancouver
Zhang D, Lv X, Jiang H, Fan Y, Liu K, Wang H, et al. AI-Enabled Microfluidics for Respiratory Pathogen Detection. Sensors. 2025;25(18):5791. doi:10.3390/s25185791
BibTeX
@article{Zhang2025,
author = {Zhang, Daoguangyao and Lv, Xuefei and Jiang, Hao and Fan, Yunlong and Liu, Kexin and Wang, Hao and Deng, Yulin},
title = {AI-Enabled Microfluidics for Respiratory Pathogen Detection},
journal = {Sensors},
year = {2025},
volume = {25},
number = {18},
pages = {5791},
doi = {10.3390/s25185791}
}
EUVIMED